SCHEMBL427586

SCHEMBL427586

CN(C)CCOC(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5576055 0.98 CHRNB2 (0.58)
SCHEMBL3894841 0.87 CA12 (0.53)
SCHEMBL8239944 0.86 CHRNB2 (0.48)
SCHEMBL17399540 0.85 CHRNB2 (0.52)
Hydrochloric Acid SCHEMBL8108272 0.84 CHRNB2 (0.47)
SCHEMBL6969789 0.84 CHRNB2 (0.47)
SCHEMBL28339539 0.82 TSHR (0.46)
SCHEMBL13608467 0.81 CHRM1 (0.56)
Urethane SCHEMBL2765857 0.81 ALOX15 (0.60)
SCHEMBL28814882 0.79 CHRNB2 (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 130 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116509816-A Ionizable lipid nanoparticle, and preparation method and application thereof 山东第一医科大学(山东省医学科学院) 2023-08-01 CN claimed
CN-110637015-A Farnesoin X receptor agonists and uses thereof 梅塔科林公司 2019-12-31 CN claimed
EP-1534766-B2 PROCESS FOR PREPARING POLYURETHANE FOAM MOMENTIVE PERFORMANCE MAT INC (US) 2018-01-17 EP claimed
CN-107531615-A Indenyl compound, pharmaceutical composition and medical application thereof ADT制药有限责任公司 2018-01-02 CN claimed
CN-107466232-A The method for treating or preventing the disease of RAS mediations ADT制药有限责任公司 2017-12-12 CN claimed
CN-104470925-B Imidazo-triazine formonitrile HCN as kinase inhibitor 百时美施贵宝公司 2017-12-05 CN claimed
EP-1534766-B1 PROCESS FOR PREPARING POLYURETHANE FOAM GEN ELECTRIC (US) 2009-02-18 EP claimed
EP-1332167-B1 PROCESS TO IMPROVE POLYURETHANE FOAM PERFORMANCE GEN ELECTRIC (US) 2008-09-17 EP claimed
EP-1534766-A1 PROCESS FOR PREPARING POLYURETHANE FOAM GENERAL ELECTRIC COMPANY (US) 2005-06-01 EP claimed
US-6818675-B2 USING REACTION PRODUCT OF TERTIARY AMINE AND ACID AS POLYMERIZATION CATALYST GENERAL ELECTRIC COMPANY 2004-11-16 US claimed
EP-1332167-A2 PROCESS TO IMPROVE POLYURETHANE FOAM PERFORMANCE Crompton Corporation (US) 2003-08-06 EP claimed
EP-1266900-A1 Carbamates of rapamycin Wyeth (US) 2002-12-18 EP claimed
US-6423756-B1 USING CATALYST SYSTEM CROMPTON CORPORATION 2002-07-23 US claimed
WO-2002048229-A2 PROCESS TO IMPROVE POLYURETHANE FOAM PERFORMANCE CROMPTON CORPORATION (US) 2002-06-20 WO claimed
EP-0593227-A1 Carbamates of rapamycin AMERICAN HOME PRODUCTS CORPORATION (US) 1994-04-20 EP claimed
US-5302584-A Immunosuppressants AMERICAN HOME PRODUCTS CORPORATION (US) 1994-04-12 US claimed
US-5084453-A Antibiotics, bactericides BANYU PHARMACEUTICAL CO., LTD. (JP) 1992-01-28 US claimed
US-4459309-A Compositions and methods of lowering intraocular pressure in the hypertensive mammalian eye THE TEXAS A&M UNIVERSITY SYSTEM (US) 1984-07-10 US claimed
EP-0051604-A1 COMPOSITIONS AND METHODS OF LOWERING INTRAOCULAR PRESSURE IN THE HYPERTENSIVE MAMMALIAN EYE CHIOU, George C.Y. (US) 1982-05-19 EP claimed
WO-1981003123-A1 COMPOSITIONS AND METHODS OF LOWERING INTRAOCULAR PRESSURE IN THE HYPERTENSIVE MAMMALIAN EYE CHIOU G 1981-11-12 WO claimed